Commonly Used Drug Might Be New Treatment Option for IBS
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).In th…
Learn MoreAlgunos antidepresivos tardan semanas en hacer efecto y los científicos podrían haber descubierto por qué
VIERNES, 13 de octubre de 2023 (HealthDay News) — La mayoría sabe que ciertos antidepresivos deben tomarse durante semanas antes de que los pacientes comiencen a ver mejoras, y ahora un nuevo estudio arroja luz sobre esa demora.Los científicos han de…
Learn MoreSome Antidepressants Take Weeks to Kick In, and Scientists May Now Know Why
THURSDAY, Oct. 12, 2023 (HealthDay News) — Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.Scientists have discovered this is because …
Learn MoreCorrer vs. medicamentos: ¿qué es más efectivo para combatir la depresión?
MIÉRCOLES, 11 de octubre de 2023 (HealthDay News) — Durante años, los médicos han considerado al ejercicio como el “antidepresivo de la naturaleza”, y ahora un nuevo estudio confirma esta idea.El hallazgo sigue una revisión de cuatro meses sobre el i…
Learn MoreRunning vs. Meds: Which Works Best to Beat Depression?
MONDAY, Oct. 9, 2023 (HealthDay News) — Exercise has been dubbed “nature’s antidepressant” by doctors for years, and now a new study confirms the notion.The finding follows a four-month look at the impact that running had on anxiety and depression wh…
Learn MoreEEG Model Predicts Response to SSRI Meds in Major Depressive Disorder
THURSDAY, Sept. 28, 2023 (HealthDay News) — For patients with major depressive disorder, an electroencephalography (EEG)-based model can predict response to selective serotonin reuptake inhibitor (SSRI) medications, according to a study published onl…
Learn MoreEstudio desmiente que un antidepresivo podría aliviar los síntomas de COVID
MARTES, 19 de septiembre de 2023 (HealthDay News) – Un ensayo clínico diseñado para probar medicamentos reutilizados contra el COVID-19 ha determinó que no hay beneficio en tomar el antidepresivo fluvoxamina (Luvox) para aliviar los síntomas del coron…
Learn MoreStudy Debunks Notion That Antidepressant Might Ease COVID Symptoms
MONDAY, Sept. 18, 2023 (HealthDay News) — A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.The study, led…
Learn More